Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer

This dose escalation study was designed to determine the maximum tolerated dose (MTD) and recommended doses (RDs) of 5-fluorouracil (5FU), folinic acid and oxaliplatin (FOLFOX) with concomitant radiotherapy in inoperable/metastatic oesophageal squamous cell carcinoma or adenocarcinoma. Patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Conroy, T, Viret, F, François, E, Seitz, J F, Boige, V, Ducreux, M, Ychou, M, Metges, J P, Giovannini, M, Yataghene, Y, Peiffert, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579679/
https://www.ncbi.nlm.nih.gov/pubmed/18841161
http://dx.doi.org/10.1038/sj.bjc.6604708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579679/
https://www.ncbi.nlm.nih.gov/pubmed/18841161
http://dx.doi.org/10.1038/sj.bjc.6604708

Ejemplares similares